Haemolytic uremic syndrome and acute mesenteric ischemia caused by interferon-alpha-2b in the treatment of Kaposi's sarcoma in an AIDS patient;Syndrome hémolytique et urémique et ischémie mésentérique aiguë lors d'un traitement par interféron alpha-2b pour une maladie de Kaposi associée au VIH

Annales de Dermatologie et de Venereologie

Volumn 134, Issue 1, 2007, Pages 65-67

  Zaraa, I ^a   Maubec, E ^a   Valeyrie Allanore, L ^a   Essig, M ^a   Charachon, A ^a   Chosidow, D ^a   Debray, M P ^a   Marinho, E ^a   Picard Dahan, C ^a   Descamps, V ^a   Crickx, B ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

ABDOMINAL PAIN; ADULT; AIDS PATIENT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; ISCHEMIA; KAPOSI SARCOMA; MESENTERY DISEASE;

EID: 33846669600     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(07)88994-0     Document Type: Article

References (9)

1. Shepherd FA, Beaulieu R, Gelmon K, Thuot CA, Sawka C, Read S, et al. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study. J Clin Oncol 1998;16:1736-42.
2. Al-Zahrani H, Gupta V, Minden MD, Messner HA, Lipton JH. Vascular events associated with alpha interferon therapy. Leuk Lymphoma 2003;44:471-5.
3. Ravandi-Kashani F, Cortes J, Talpaz M, Kantarjian HM. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect? Cancer 1999;85:2583-8.
4. Creput C, Auffret N, Samuel D, Jian R, Hill G, Nochy D. Cutaneous thrombotic microangiopathy during treatment with alpha-interferon for chronic hepatitis J Hepatol 2002;37:871-2.
5. Zuber J, Martinez F, Droz D, Oksenhendler E, Legendre C. Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literature. Medicine 2002;81:321-31.
6. Ohashi N, Yonemura K, Sugiura T, Isozaki T, Togawa A, Fujigaki Y, et al. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha. Am J Kidney Dis 2003;41:E10.
7. Kelleher P, Severn A, Tomson C, Lucas S, Parkin J, Pinching A, et al. The haemolytic uraemic syndrome in patients with AIDS. Genitourin Med 1996;72:172-5.
8. Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol 2002;12:1179-87.
9. Pisoni R, Ruggenenti P, Remuzzi G. Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf 2001;24:491-501.